TOPIRAMATE

NDC 72603-123 · NorthStar RxLLC

Generic nametopiramate

Dosage formCAPSULE, EXTENDED RELEASE

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength150 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

72603-123-01 — 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-123-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71610-486 — Topiramate, 71610-492 — Topiramate, 71610-493 — Topiramate, 72162-2480 — topiramate, 72162-2481 — topiramate, 72162-2482 — topiramate, 72162-2483 — topiramate, 72603-120 — topiramate, 72603-121 — topiramate, 72603-122 — topiramate, 72603-124 — topiramate, 72789-004 — Topiramate, 72789-443 — Topiramate, 72789-471 — Topiramate, 72865-313 — Topiramate, 72865-314 — Topiramate, 72865-315 — Topiramate, 72865-316 — Topiramate, 72888-228 — Topiramate, 72888-229 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels